Notably, Stat3 is constitutively active in invasive breast cancers (Watson and Miller, 1995) and, when expressed in tumour epithelial cells, is crucially important in promoting an immunosuppressive microenvironment both during tumour initiation and progression (Jones et al., 2016). Here, STAT3 is linked to neoplasm.